Skip to main content

Advertisement

SpringerLink
Log in

Has the time come to implement gene therapy for sickle cell disease?

  • News and Views
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. Lancet 376:2018–2031

    Article  CAS  Google Scholar 

  2. Faber M, Koshy Mand Kinney T (1985) Cooperative study of sickle cell disease: demographic and socioeconomic characteristics of patients and families with sickle cell disease. J Chronic Dis 38:495–505

    Article  Google Scholar 

  3. Danielson CFM (2002) The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Therap Apher 6:24–31

    Article  Google Scholar 

  4. Park SH, Lee CM, Deshmukh H, Bao G (2016) Therapeutic Crispr/Cas9 genome editing for treating sickle cell disease. Blood 128:4703–4706

    Article  Google Scholar 

  5. Roux C, Amiot C, Agnani G, Arbey-Gindre F, Lagre P, Aubard Y, Deconinick E, Piver P, Rohrlich AG (2009) Successful pregnancy after allogeneic bone marrow transplantation followed by ovarian tissue autograft in a sickle cell patient. Blood 114:4482

    Article  Google Scholar 

  6. Anzalone A, Randolph P, Davis J, Sousa A, Koblon L, Levy J, Chen P, Wilson C, Newby G, Reguram A, Lui D (2019) Search-and replace genome editing without double-strand breaks or donor DNA. Nature 576:149–157

    Article  CAS  Google Scholar 

  7. Day E, Kearns P, Taylor C, Bradley A (2014) Transplant between monozygotic twins: how identical are they. Transplantation 98:485–489

    Article  Google Scholar 

  8. Bolaños-Meade J, Brodsky R (2009) HSS Public Access Blood and marrow transplantation for sickle cell disease: overcoming barriers to success. Curr Opin Oncol 21:158–161

    Article  Google Scholar 

  9. Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG (2009) The cost of health care for children and adults with sickle cell disease. Am J Hematol 84:323–327

    Article  Google Scholar 

  10. Memi F, Ntokou A, Papangeli I (2018) CRISPR/Casa9 gene-editing: Research technologyies, clinical applications and ethical considerations. Semin Perinatol 42:487–500

    Article  Google Scholar 

  11. Flinn A, Gennery A (2018) Adenosine deaminase deficiency: a review. Flinn Gennery Orpanet J Rare Dis 13:65–72

    Article  Google Scholar 

  12. Talbot K, Tizzano EF (2017) The clinical landscape for SMA in a new therapeutic era. Gene Ther 24:529–533

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Advocate Illinois Masonic Hospital, Chicago, USA

    Norman Ginsberg

  2. Department of Obstetrics and Gynecology, Northwestern Feinberg School of Medicine, 1520 Eastwood Ave, Highland Park, IL, 60035, USA

    Norman Ginsberg

  3. Prentice Hospital, Chicago, USA

    Lee P. Shulman

  4. Division of Clinical Genetics, Department of Obstetrics and Gynecology, Northwestern Feinberg School of Medicine, Chicago, USA

    Lee P. Shulman

Authors
  1. Norman Ginsberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lee P. Shulman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

NG project development and manuscript writing. LS manuscript writing and editing.

Corresponding author

Correspondence to Norman Ginsberg.

Ethics declarations

Conflict of interest

No conflict of interest/competing interest of either authors

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ginsberg, N., Shulman, L.P. Has the time come to implement gene therapy for sickle cell disease?. Arch Gynecol Obstet 302, 1313–1316 (2020). https://doi.org/10.1007/s00404-020-05723-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-020-05723-y

Search

Navigation